Canova C R, Kuhn M, Reinhart W H
Medizinische Klinik, Kantonsspital Chur.
Schweiz Med Wochenschr. 1995 Dec 26;125(51-52):2511-7.
Tuberculosis is the world's foremost cause of death from a single infectious agent in adults. During the past decade the nature and magnitude of the problem of tuberculosis have dramatically changed. Much of what physicians have learned about this disease is no longer true and tuberculosis has become a new entity. Migration from developing areas with a high prevalence of tuberculosis to industrialized countries, and the problem of HIV infection, have introduced new components to the epidemiology. We report three cases of young immigrants with lymph node tuberculosis. One patient was successfully treated with the usual 9-month-regimen. The other 2 patients, however, developed new lymph nodes or enlargement of existing nodes during treatment. They underwent further examinations, including surgical biopsies, because of diagnostic uncertainty (tuberculosis, superinfection or lymphoma). Finally the 2 patients were successfully treated with antituberculous agents for 12 and 15 months. These cases prompted a review of the literature and a reevaluation of the management of lymph node tuberculosis, including the value of surgical biopsy in the diagnosis of tuberculous lymphadenitis. We conclude that selective surgical biopsies should be recommended for differential diagnosis of tuberculous lymphadenitis. Histological examination (caseating epitheloid cell granulomas and giant cell formation) and microbiological examination (Ziehl-Neelsen staining and culture of native material) should be performed. Newer methods, such as amplification and detection of mycobacterial DNA, are rapid and sensitive tests helpful for diagnosis. Lymph nodes may increase in size and new nodes may appear both during and after chemotherapy, without indicating a failure of treatment or relapse. The usual treatment is a 9-month-regimen with rifamipicin, isoniazid, pyrazinamid and ethambutol. Prolonged or modified regimens are, however, necessary in some individuals.
结核病是全球成年人因单一感染源导致死亡的首要原因。在过去十年中,结核病问题的性质和严重程度发生了巨大变化。医生们此前对这种疾病的许多认知已不再正确,结核病已成为一种新的病症。从结核病高发的发展中地区向工业化国家的移民,以及艾滋病毒感染问题,给流行病学带来了新的因素。我们报告了三例年轻移民患淋巴结结核的病例。一名患者通过常规的9个月治疗方案成功治愈。然而,另外两名患者在治疗期间出现了新的淋巴结或现有淋巴结肿大。由于诊断存在不确定性(结核病、重复感染或淋巴瘤),他们接受了进一步检查,包括手术活检。最终,这两名患者接受抗结核药物治疗12个月和15个月后成功治愈。这些病例促使我们对文献进行回顾,并重新评估淋巴结结核的治疗方法,包括手术活检在结核性淋巴结炎诊断中的价值。我们得出结论,对于结核性淋巴结炎的鉴别诊断,应推荐进行选择性手术活检。应进行组织学检查(干酪样上皮样细胞肉芽肿和巨细胞形成)和微生物学检查(萋-尼染色和对原始材料进行培养)。较新的方法,如分枝杆菌DNA的扩增和检测,是快速且灵敏的检测方法,有助于诊断。在化疗期间及化疗后,淋巴结可能会增大,新的淋巴结可能会出现,但这并不表明治疗失败或复发。常规治疗是使用利福喷汀、异烟肼、吡嗪酰胺和乙胺丁醇进行9个月的治疗方案。然而,在某些个体中需要延长疗程或采用改良方案。